CarboFix Orhtopedics, Ltd. appears in FDA 510(k) records as the applicant for CarboClear® Cervical Navigated Instruments, a Class II orthopedic stereotaxic instrument under product code OLO and regulation 882.4560, with a substantially equivalent decision dated October 9, 2026. The filing lists an address in Herzeliya, Israel, and a contact named Yael Rubin. A separate FDA record for K254045 names CarboFix Orthopedics, Ltd. as applicant for the CarboClear® Posterior Cervical Screw System and CarboClear® Hybrid Posterior Cervical Screw System. The manufacturer's own spine site describes spinal implants made of continuous carbon fiber reinforced polymer. [1][2][3][4]

The K263154 cervical navigated instruments filing

FDA record K263154 covers CarboClear® Cervical Navigated Instruments, classified as an orthopedic stereotaxic instrument in Class II under regulation 882.4560 and product code OLO, with a neurology advisory committee assignment. The decision was substantially equivalent, dated October 9, 2026, following receipt on September 9, 2026, and the clearance type is recorded as special. The applicant name in the record is CarboFix Orhtopedics, Ltd., at 11 Ha'Hoshlim St., Herzeliya, Israel, with Yael Rubin listed as contact. [1]

The same clearance appears in the FDA list of 510(k) final decisions rendered since October 1, 2026, where K263154 is recorded as substantially equivalent for CarboClear® Cervical Navigated Instruments with CarboFix Orhtopedics, Ltd. as applicant. That listing places the decision on October 9, 2026, matching the individual record. [7]

Posterior cervical screw system record

A separate FDA 510(k), K254045, names CarboFix Orthopedics, Ltd. as applicant for the CarboClear® Posterior Cervical Screw System and CarboClear® Hybrid Posterior Cervical Screw System. The FDA letter is dated March 16, 2026, and identifies regulation 21 CFR 888.3075 for the Posterior Cervical Screw System, Class II, product code NKG, with an orthopedic review panel. The submission is dated December 16, 2025 and received December 17, 2025. [3]

The FDA 510(k) database entry for K254045 lists the device classification name as Posterior Cervical Screw System and the device names as CarboClear® Posterior Cervical Screw System and CarboClear® Hybrid Posterior. The page carries a last-updated date of October 26, 2026. [2]

Earlier pedicle screw clearances

An FDA substantial equivalence determination for K240846, dated April 25, 2024, names CarboFix Orthopedics Ltd. and covers the CarboClear® Hybrid Pedicle Screw System, CarboClear® Hybrid Navigated Instruments, CarboClear® Hybrid Fenestrated Pedicle Screw System with High V+® Bone Cement, and CarboClear® X Fenestrated Pedicle Screw System with High V+® Bone Cement. The document compares the Hybrid Pedicle Screw System against a primary predicate and references earlier CarboClear® X Pedicle Screw System clearances K210716, K231280 and K233944. [5]

Published product documentation

The manufacturer's spine site lists cervical products including a Posterior Cervical Screw System, Hybrid Posterior Cervical Screw System, Cervical Plate, Cervical Cage and Cervical VBR, alongside a CarboClear Lumbar Cage, Thoracolumbar VBR System, CarboClear X Pedicle Screw System and a Hybrid MIS Pedicle Screw. The site states that its spinal implants are made of continuous carbon fiber reinforced polymer and presents carbon fiber in relation to CT/MRI, follow-up and radiation therapy. The same site gives CarboFix Orthopedics Ltd. headquarters contact details at 11 Ha'hoshlim St., Herzeliya, Israel, and a US contact for CarboFix Spine Inc. in Richardson, Texas. [4]

The corporate site presents CarboFix Spine and CarboFix Trauma as its two areas and lists trauma products including a Trochanteric (PF) Nail and Ankle Arthrodesis. It also provides links to trauma publications and surgeon presentations. [6]